Abstract

BackgroundSemi-quantification methods are well established in the clinic for assisted reporting of (I123) Ioflupane images. Arguably, these are limited diagnostic tools. Recent research has demonstrated the potential for improved classification performance offered by machine learning algorithms. A direct comparison between methods is required to establish whether a move towards widespread clinical adoption of machine learning algorithms is justified.This study compared three machine learning algorithms with that of a range of semi-quantification methods, using the Parkinson’s Progression Markers Initiative (PPMI) research database and a locally derived clinical database for validation. Machine learning algorithms were based on support vector machine classifiers with three different sets of features:Voxel intensitiesPrincipal components of image voxel intensitiesStriatal binding radios from the putamen and caudate.Semi-quantification methods were based on striatal binding ratios (SBRs) from both putamina, with and without consideration of the caudates. Normal limits for the SBRs were defined through four different methods:Minimum of age-matched controlsMean minus 1/1.5/2 standard deviations from age-matched controlsLinear regression of normal patient data against age (minus 1/1.5/2 standard errors)Selection of the optimum operating point on the receiver operator characteristic curve from normal and abnormal training dataEach machine learning and semi-quantification technique was evaluated with stratified, nested 10-fold cross-validation, repeated 10 times.ResultsThe mean accuracy of the semi-quantitative methods for classification of local data into Parkinsonian and non-Parkinsonian groups varied from 0.78 to 0.87, contrasting with 0.89 to 0.95 for classifying PPMI data into healthy controls and Parkinson’s disease groups. The machine learning algorithms gave mean accuracies between 0.88 to 0.92 and 0.95 to 0.97 for local and PPMI data respectively.ConclusionsClassification performance was lower for the local database than the research database for both semi-quantitative and machine learning algorithms. However, for both databases, the machine learning methods generated equal or higher mean accuracies (with lower variance) than any of the semi-quantification approaches. The gain in performance from using machine learning algorithms as compared to semi-quantification was relatively small and may be insufficient, when considered in isolation, to offer significant advantages in the clinical context.

Highlights

  • Semi-quantification methods are well established in the clinic for assisted reporting of (I123) Ioflupane images

  • There appeared to be little influence on performance results when Striatal binding ratio (SBR) results from the caudate were added to those of the putamen

  • Recent research [17] suggests that the sensitivity of this approach is very low when calibration is not performed between different camera systems and is significantly reduced when correction is not

Read more

Summary

Introduction

Semi-quantification methods are well established in the clinic for assisted reporting of (I123) Ioflupane images. Recent research has demonstrated the potential for improved classification performance offered by machine learning algorithms. A direct comparison between methods is required to establish whether a move towards widespread clinical adoption of machine learning algorithms is justified. This study compared three machine learning algorithms with that of a range of semi-quantification methods, using the Parkinson’s Progression Markers Initiative (PPMI) research database and a locally derived clinical database for validation. Machine learning algorithms were based on support vector machine classifiers with three different sets of features: Voxel intensities Principal components of image voxel intensities Striatal binding radios from the putamen and caudate

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call